[Ip-health] European Parliaments's call to the use of TRIPS flexibilities through 2 Resolutions

[Alexandra HEUMBER]

This is a multipart message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
FYI please find below two Resolutions adopted by the European Parliament=0D
on Access to medicines and TRIPS (use of the TRIPS flexibilities).=0D
=0D
1- The European Parliament Resolution on Trade and economic relation with=
=0D
the Association of South Est Asian Nations (ASEAN)- Paragraph 13 and above=
=0D
all 14 below.=0D
http://www.europarl.europa.eu/sides/getDoc.do?pubRef=3D-//EP//TEXT+TA+P6-TA=
-2008-0195+0+DOC+XML+V0//EN&language=3DEN=0D
=0D
"13.  Attaches particular importance to the fight against counterfeit=0D
pharmaceuticals which represent unfair competition and a danger to=0D
consumers; at the same time, points out that nothing in the agreement=0D
should create legal or practical obstacles to the maximum use of=0D
flexibilities set out in the Declaration amending the Trade-Related=0D
Aspects of Intellectual Property Rights Agreement (TRIPS agreement) and=0D
access to medicines and calls on the Commission negotiators to take full=0D
account of the points set out in its above mentioned resolution of 12 July=
=0D
2007 on this topic;=0D
14.  Recalls the EU commitment to support the Doha Declaration and the use=
=0D
of TRIPS flexibilities in favour of public health and of access to=0D
medicines in developing countries; therefore calls on the Commission to do=
=0D
nothing that could undermine the Thai government's efforts to ensure=0D
access to medicines for all its residents;"=0D
=0D
2- The Euro-Latin American Parliamentary Assembly's  Resolution adopted=0D
May 1, in Lima. Paragraph 5=0D
http://www.europarl.europa.eu/intcoop/eurolat/assembly/plenary_sessions/lim=
a_2008_htm/adopted_docs/resolution_trade_committee_en.pdf=0D
=0D
"5. Supports the developing countries which use the =E2=80=98flexibilities=
=E2=80=99 built=0D
into the TRIPS Agreement and recognised by the Doha Declaration in order=0D
to be able to provide essential medicines at affordable prices under their=
=0D
domestic public health programmes; notes with concern that they are not=0D
being put into practice and asks industrialised countries to refrain from=
=0D
including in bilateral agreements any provision that restricts access to=0D
medicines; calls for the Doha Declaration commitments to be honoured in=0D
order to facilitate the production and import of generic medicines;"=0D
=0D
Alexandra Heumber=0D
EU Advocacy Liaison Officer=0D
M=C3=A9decins Sans Fronti=C3=A8res=0D
Access to Essential Medicines Campaign=0D
Rue Dupr=C3=A9, 94. 1090 Brussels=0D
++32 (0) 2 474 75 09 (Dir off)=0D
++ 32 (0) 479 514 900 (Mob)=0D
++ 32 (0) 2 474 75 75 (Fax)=0D
=0D